Zhengye Biotechnology ZYBT Gains Nearly 5 Testing Key Resistance at 089 Treasury Yield Surge Challenges RiskFree Label Opens Doors in Intermediates and High Yield MITN Q1 2026 Earnings Earnings Beat on Solid Net Investment Income Ferraris EV Launch Sparks Stock Decline but Potential Silver Lining Emerges